Stock Analysis on Net

Abbott Laboratories (NYSE:ABT) 

Analysis of Solvency Ratios

Microsoft Excel

Solvency Ratios (Summary)

Abbott Laboratories, solvency ratios

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Debt Ratios
Debt to equity 0.30 0.38 0.46 0.50 0.57
Debt to equity (including operating lease liability) 0.32 0.41 0.49 0.54 0.61
Debt to capital 0.23 0.28 0.31 0.34 0.36
Debt to capital (including operating lease liability) 0.24 0.29 0.33 0.35 0.38
Debt to assets 0.17 0.20 0.23 0.24 0.26
Debt to assets (including operating lease liability) 0.19 0.22 0.24 0.26 0.27
Financial leverage 1.71 1.90 2.03 2.10 2.21
Coverage Ratios
Interest coverage 13.55 11.46 15.89 16.41 10.10
Fixed charge coverage 8.58 7.71 10.10 10.21 6.68

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Abbott Laboratories debt to equity ratio improved from 2022 to 2023 and from 2023 to 2024.
Debt to equity ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. Abbott Laboratories debt to equity ratio (including operating lease liability) improved from 2022 to 2023 and from 2023 to 2024.
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Abbott Laboratories debt to capital ratio improved from 2022 to 2023 and from 2023 to 2024.
Debt to capital ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. Abbott Laboratories debt to capital ratio (including operating lease liability) improved from 2022 to 2023 and from 2023 to 2024.
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Abbott Laboratories debt to assets ratio improved from 2022 to 2023 and from 2023 to 2024.
Debt to assets ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. Abbott Laboratories debt to assets ratio (including operating lease liability) improved from 2022 to 2023 and from 2023 to 2024.
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Abbott Laboratories financial leverage ratio decreased from 2022 to 2023 and from 2023 to 2024.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Abbott Laboratories interest coverage ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024.
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. Abbott Laboratories fixed charge coverage ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024.

Debt to Equity

Abbott Laboratories, debt to equity calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Short-term borrowings 213
Current portion of long-term debt 1,500 1,080 2,251 754 7
Long-term debt, excluding current portion 12,625 13,599 14,522 17,296 18,527
Total debt 14,125 14,679 16,773 18,050 18,747
 
Total Abbott shareholders’ investment 47,664 38,603 36,686 35,802 32,784
Solvency Ratio
Debt to equity1 0.30 0.38 0.46 0.50 0.57
Benchmarks
Debt to Equity, Competitors2
Cigna Group 0.78 0.67 0.69 0.71 0.65
CVS Health Corp. 0.88 0.81 0.74 0.75 0.93
Elevance Health Inc. 0.76 0.64 0.66 0.64 0.60
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00
Medtronic PLC 0.50 0.47 0.46 0.51 0.49
UnitedHealth Group Inc. 0.83 0.70 0.74 0.64 0.66
Debt to Equity, Sector
Health Care Equipment & Services 0.67 0.62 0.62 0.62 0.66
Debt to Equity, Industry
Health Care 0.87 0.81 0.72 0.79 0.90

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Debt to equity = Total debt ÷ Total Abbott shareholders’ investment
= 14,125 ÷ 47,664 = 0.30

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Abbott Laboratories debt to equity ratio improved from 2022 to 2023 and from 2023 to 2024.

Debt to Equity (including Operating Lease Liability)

Abbott Laboratories, debt to equity (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Short-term borrowings 213
Current portion of long-term debt 1,500 1,080 2,251 754 7
Long-term debt, excluding current portion 12,625 13,599 14,522 17,296 18,527
Total debt 14,125 14,679 16,773 18,050 18,747
Operating lease liability, current (included in Other accrued liabilities) 254 245 230 245 241
Operating lease liability, non-current 896 949 943 956 902
Total debt (including operating lease liability) 15,275 15,873 17,946 19,251 19,890
 
Total Abbott shareholders’ investment 47,664 38,603 36,686 35,802 32,784
Solvency Ratio
Debt to equity (including operating lease liability)1 0.32 0.41 0.49 0.54 0.61
Benchmarks
Debt to Equity (including Operating Lease Liability), Competitors2
Cigna Group 0.78 0.68 0.70 0.73 0.67
CVS Health Corp. 1.10 1.04 1.00 1.01 1.23
Elevance Health Inc. 0.78 0.66 0.69 0.67 0.63
Intuitive Surgical Inc. 0.01 0.01 0.01 0.01 0.01
Medtronic PLC 0.52 0.49 0.48 0.53 0.51
UnitedHealth Group Inc. 0.88 0.76 0.80 0.70 0.73
Debt to Equity (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.74 0.69 0.70 0.70 0.75
Debt to Equity (including Operating Lease Liability), Industry
Health Care 0.92 0.86 0.78 0.84 0.96

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Debt to equity (including operating lease liability) = Total debt (including operating lease liability) ÷ Total Abbott shareholders’ investment
= 15,275 ÷ 47,664 = 0.32

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to equity ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. Abbott Laboratories debt to equity ratio (including operating lease liability) improved from 2022 to 2023 and from 2023 to 2024.

Debt to Capital

Abbott Laboratories, debt to capital calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Short-term borrowings 213
Current portion of long-term debt 1,500 1,080 2,251 754 7
Long-term debt, excluding current portion 12,625 13,599 14,522 17,296 18,527
Total debt 14,125 14,679 16,773 18,050 18,747
Total Abbott shareholders’ investment 47,664 38,603 36,686 35,802 32,784
Total capital 61,789 53,282 53,459 53,852 51,531
Solvency Ratio
Debt to capital1 0.23 0.28 0.31 0.34 0.36
Benchmarks
Debt to Capital, Competitors2
Cigna Group 0.44 0.40 0.41 0.42 0.40
CVS Health Corp. 0.47 0.45 0.42 0.43 0.48
Elevance Health Inc. 0.43 0.39 0.40 0.39 0.38
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00
Medtronic PLC 0.33 0.32 0.31 0.34 0.33
UnitedHealth Group Inc. 0.45 0.41 0.43 0.39 0.40
Debt to Capital, Sector
Health Care Equipment & Services 0.40 0.38 0.38 0.38 0.40
Debt to Capital, Industry
Health Care 0.46 0.45 0.42 0.44 0.47

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Debt to capital = Total debt ÷ Total capital
= 14,125 ÷ 61,789 = 0.23

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Abbott Laboratories debt to capital ratio improved from 2022 to 2023 and from 2023 to 2024.

Debt to Capital (including Operating Lease Liability)

Abbott Laboratories, debt to capital (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Short-term borrowings 213
Current portion of long-term debt 1,500 1,080 2,251 754 7
Long-term debt, excluding current portion 12,625 13,599 14,522 17,296 18,527
Total debt 14,125 14,679 16,773 18,050 18,747
Operating lease liability, current (included in Other accrued liabilities) 254 245 230 245 241
Operating lease liability, non-current 896 949 943 956 902
Total debt (including operating lease liability) 15,275 15,873 17,946 19,251 19,890
Total Abbott shareholders’ investment 47,664 38,603 36,686 35,802 32,784
Total capital (including operating lease liability) 62,939 54,476 54,632 55,053 52,674
Solvency Ratio
Debt to capital (including operating lease liability)1 0.24 0.29 0.33 0.35 0.38
Benchmarks
Debt to Capital (including Operating Lease Liability), Competitors2
Cigna Group 0.44 0.40 0.41 0.42 0.40
CVS Health Corp. 0.52 0.51 0.50 0.50 0.55
Elevance Health Inc. 0.44 0.40 0.41 0.40 0.39
Intuitive Surgical Inc. 0.01 0.01 0.01 0.01 0.01
Medtronic PLC 0.34 0.33 0.32 0.35 0.34
UnitedHealth Group Inc. 0.47 0.43 0.45 0.41 0.42
Debt to Capital (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.43 0.41 0.41 0.41 0.43
Debt to Capital (including Operating Lease Liability), Industry
Health Care 0.48 0.46 0.44 0.46 0.49

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Debt to capital (including operating lease liability) = Total debt (including operating lease liability) ÷ Total capital (including operating lease liability)
= 15,275 ÷ 62,939 = 0.24

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to capital ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. Abbott Laboratories debt to capital ratio (including operating lease liability) improved from 2022 to 2023 and from 2023 to 2024.

Debt to Assets

Abbott Laboratories, debt to assets calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Short-term borrowings 213
Current portion of long-term debt 1,500 1,080 2,251 754 7
Long-term debt, excluding current portion 12,625 13,599 14,522 17,296 18,527
Total debt 14,125 14,679 16,773 18,050 18,747
 
Total assets 81,414 73,214 74,438 75,196 72,548
Solvency Ratio
Debt to assets1 0.17 0.20 0.23 0.24 0.26
Benchmarks
Debt to Assets, Competitors2
Cigna Group 0.21 0.20 0.22 0.22 0.21
CVS Health Corp. 0.26 0.25 0.23 0.24 0.28
Elevance Health Inc. 0.27 0.23 0.23 0.24 0.23
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00
Medtronic PLC 0.28 0.27 0.27 0.28 0.27
UnitedHealth Group Inc. 0.26 0.23 0.23 0.22 0.22
Debt to Assets, Sector
Health Care Equipment & Services 0.24 0.23 0.23 0.23 0.24
Debt to Assets, Industry
Health Care 0.30 0.29 0.27 0.28 0.31

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Debt to assets = Total debt ÷ Total assets
= 14,125 ÷ 81,414 = 0.17

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Abbott Laboratories debt to assets ratio improved from 2022 to 2023 and from 2023 to 2024.

Debt to Assets (including Operating Lease Liability)

Abbott Laboratories, debt to assets (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Short-term borrowings 213
Current portion of long-term debt 1,500 1,080 2,251 754 7
Long-term debt, excluding current portion 12,625 13,599 14,522 17,296 18,527
Total debt 14,125 14,679 16,773 18,050 18,747
Operating lease liability, current (included in Other accrued liabilities) 254 245 230 245 241
Operating lease liability, non-current 896 949 943 956 902
Total debt (including operating lease liability) 15,275 15,873 17,946 19,251 19,890
 
Total assets 81,414 73,214 74,438 75,196 72,548
Solvency Ratio
Debt to assets (including operating lease liability)1 0.19 0.22 0.24 0.26 0.27
Benchmarks
Debt to Assets (including Operating Lease Liability), Competitors2
Cigna Group 0.21 0.21 0.22 0.22 0.22
CVS Health Corp. 0.33 0.32 0.31 0.33 0.37
Elevance Health Inc. 0.27 0.24 0.24 0.25 0.24
Intuitive Surgical Inc. 0.01 0.01 0.01 0.01 0.01
Medtronic PLC 0.29 0.28 0.27 0.29 0.28
UnitedHealth Group Inc. 0.27 0.25 0.25 0.24 0.24
Debt to Assets (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.27 0.25 0.26 0.26 0.28
Debt to Assets (including Operating Lease Liability), Industry
Health Care 0.32 0.31 0.29 0.30 0.33

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Debt to assets (including operating lease liability) = Total debt (including operating lease liability) ÷ Total assets
= 15,275 ÷ 81,414 = 0.19

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to assets ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. Abbott Laboratories debt to assets ratio (including operating lease liability) improved from 2022 to 2023 and from 2023 to 2024.

Financial Leverage

Abbott Laboratories, financial leverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Total assets 81,414 73,214 74,438 75,196 72,548
Total Abbott shareholders’ investment 47,664 38,603 36,686 35,802 32,784
Solvency Ratio
Financial leverage1 1.71 1.90 2.03 2.10 2.21
Benchmarks
Financial Leverage, Competitors2
Cigna Group 3.80 3.30 3.21 3.29 3.09
CVS Health Corp. 3.35 3.27 3.21 3.10 3.32
Elevance Health Inc. 2.83 2.77 2.83 2.70 2.61
Intuitive Surgical Inc. 1.14 1.16 1.17 1.14 1.15
Medtronic PLC 1.79 1.77 1.73 1.81 1.79
UnitedHealth Group Inc. 3.22 3.08 3.16 2.96 3.01
Financial Leverage, Sector
Health Care Equipment & Services 2.78 2.72 2.72 2.67 2.71
Financial Leverage, Industry
Health Care 2.86 2.79 2.67 2.77 2.94

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Financial leverage = Total assets ÷ Total Abbott shareholders’ investment
= 81,414 ÷ 47,664 = 1.71

2 Click competitor name to see calculations.

Solvency ratio Description The company
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Abbott Laboratories financial leverage ratio decreased from 2022 to 2023 and from 2023 to 2024.

Interest Coverage

Abbott Laboratories, interest coverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Net earnings 13,402 5,723 6,933 7,071 4,495
Less: Net earnings from discontinued operations, net of taxes 24
Add: Income tax expense (6,389) 941 1,373 1,140 497
Add: Interest expense 559 637 558 533 546
Earnings before interest and tax (EBIT) 7,572 7,301 8,864 8,744 5,514
Solvency Ratio
Interest coverage1 13.55 11.46 15.89 16.41 10.10
Benchmarks
Interest Coverage, Competitors2
Cigna Group 4.51 4.94 7.43 6.22 8.76
CVS Health Corp. 3.08 5.20 3.46 5.16 4.36
Elevance Health Inc. 7.67 8.49 10.13 10.93 8.96
Intuitive Surgical Inc.
Medtronic PLC 7.73 9.43 10.98 5.21 4.71
UnitedHealth Group Inc. 6.14 9.97 13.59 14.44 13.47
Interest Coverage, Sector
Health Care Equipment & Services 5.98 8.03 9.31 8.96 7.89
Interest Coverage, Industry
Health Care 5.70 7.09 12.71 12.24 7.71

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Interest coverage = EBIT ÷ Interest expense
= 7,572 ÷ 559 = 13.55

2 Click competitor name to see calculations.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Abbott Laboratories interest coverage ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024.

Fixed Charge Coverage

Abbott Laboratories, fixed charge coverage calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Net earnings 13,402 5,723 6,933 7,071 4,495
Less: Net earnings from discontinued operations, net of taxes 24
Add: Income tax expense (6,389) 941 1,373 1,140 497
Add: Interest expense 559 637 558 533 546
Earnings before interest and tax (EBIT) 7,572 7,301 8,864 8,744 5,514
Add: Operating lease cost 366 356 355 359 329
Earnings before fixed charges and tax 7,938 7,657 9,219 9,103 5,843
 
Interest expense 559 637 558 533 546
Operating lease cost 366 356 355 359 329
Fixed charges 925 993 913 892 875
Solvency Ratio
Fixed charge coverage1 8.58 7.71 10.10 10.21 6.68
Benchmarks
Fixed Charge Coverage, Competitors2
Cigna Group 4.51 4.64 6.87 5.61 7.84
CVS Health Corp. 2.14 3.15 2.16 3.03 2.75
Elevance Health Inc. 6.93 7.51 8.82 8.48 6.10
Intuitive Surgical Inc. 79.87 74.09 63.52 93.66 58.48
Medtronic PLC 5.88 6.90 7.79 4.31 3.98
UnitedHealth Group Inc. 4.78 7.27 8.77 8.80 8.51
Fixed Charge Coverage, Sector
Health Care Equipment & Services 4.49 5.67 6.11 5.87 5.31
Fixed Charge Coverage, Industry
Health Care 4.66 5.52 9.02 8.67 5.70

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= 7,938 ÷ 925 = 8.58

2 Click competitor name to see calculations.

Solvency ratio Description The company
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. Abbott Laboratories fixed charge coverage ratio deteriorated from 2022 to 2023 but then slightly improved from 2023 to 2024.